Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Genomics Precision Diagnostic > Prenatal > Oligohydramnios Precision Panel

Oligohydramnios Precision Panel

Oligohydramnios is defined as an abnormally low volume of amniotic fluid. Amniotic fluid is crucial for fetal development and growth, serving as protection from trauma and infection and helping in the development of the fetal lungs.
Overview
Indication
Clinical Utility
Genes & Diseases
Methodology
References

Overview

  • Oligohydramnios is defined as an abnormally low volume of amniotic fluid. Amniotic fluid is crucial for fetal development and growth, serving as protection to the fetus from trauma and infection as well as helping in the development of the fetal lungs. Normal amniotic fluid varies, on average it can reach up to 800-1000mL. An excess of amniotic fluid is termed polyhydramnios, decreased amniotic fluid is oligohydramnios. It occurs in approximately 11% of all pregnancies. Causes of oligohydramnios include rupture of membranes, fetal urinary tract blockage (renal agenesis, posterior urethral valves or polycystic kidney disease) which can have a genetic background associated with other genetic conditions. The mortality is high, especially if it is diagnosed during the first trimester as it can increase the risk for chest wall fixation and pulmonary hypoplasia.  

  • The Igenomix Oligohydramnios Precision Panel can be used to make a directed and accurate differential diagnosis of oligohydramnios and uncover the genetics underlying this clinical sign ultimately leading to a better management and achieve a healthy baby at home. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

Indication

  • The Igenomix Oligohydramnios Precision Panel is indicated for those patients with clinical and ultrasound findings of oligohydramnios presenting with: 
    • Abdominal discomfort 
    • Amniotic fluid index < 7cm 
    • Fetal structure survey revealing congenital abnormalities

Clinical Utility

The clinical utility of this panel is: 

  • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
  • Early initiation of treatment with a multidisciplinary team for hospitalization and obstetric management in case of preterm delivery and provide adequate hydration. 
  • Risk assessment of asymptomatic family members according to the mode of inheritance. 

Genes & Diseases

Methodology

References

See scientific referrals

Dias, T., Sairam, S., & Kumarasiri, S. (2014). Ultrasound diagnosis of fetal renal abnormalities. Best practice & research. Clinical obstetrics & gynaecology, 28(3), 403–415. https://doi.org/10.1016/j.bpobgyn.2014.01.009 

Gimpel, C., Avni, F. E., Bergmann, C., Cetiner, M., Habbig, S., Haffner, D., König, J., Konrad, M., Liebau, M. C., Pape, L., Rellensmann, G., Titieni, A., von Kaisenberg, C., Weber, S., Winyard, P., & Schaefer, F. (2018). Perinatal Diagnosis, Management, and Follow-up of Cystic Renal Diseases: A Clinical Practice Recommendation With Systematic Literature Reviews. JAMA pediatrics, 172(1), 74–86. https://doi.org/10.1001/jamapediatrics.2017.3938 

Sahin, E., Madendag, Y., Tayyar, A., Sahin, M., Col Madendag, I., & Acmaz, G. et al. (2017). Perinatal outcomes in uncomplicated late preterm pregnancies with borderline oligohydramnios. The Journal Of Maternal-Fetal & Neonatal Medicine, 31(23), 3085-3088. doi: 10.1080/14767058.2017.1364722 

Magann, E., Haas, D., Hill, J., Chauhan, S., Watson, E., & Learman, L. (2011). Oligohydramnios, Small for Gestational Age and Pregnancy Outcomes: An Analysis Using Precise Measures. Gynecologic And Obstetric Investigation, 72(4), 239-244. doi: 10.1159/000324570 

Leung J. C. (2014). Inherited renal diseases. Current pediatric reviews, 10(2), 95–100. https://doi.org/10.2174/157339631002140513101755 

descargar

Detail description

Download

Request Information

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information